ALAAF study
- Conditions
- ot applicable
- Registration Number
- NL-OMON22635
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Elective caesarean section, 37+0 – 41+6 weeks gestation, prenatal screening/diagnostics without congenital anomalies or syndromes
Exclusion Criteria
Emergency caesarean section, multiplet pregnancy, maternal coagulation disorders, presence of maternal irregulair antibodies, maternal fever (>38 degrees Celsius) directly prior to the caesarean section, caesarean sectio due to placenta praevia, prolonged rupture of membranes (>24hours), and the performance of a caesarean section under general anesthesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobine (Hb), hematocrit (Ht) in the neonate on the second day post delivery.
- Secondary Outcome Measures
Name Time Method Maternal: amount of blood loss during the caesarean section, wound infections or endometritis, need for bloodtranfusions post caesarean section. <br>Neonatal: APGAR score, rectal temperature 10 minutes post delivery, serum bilirubin on the second day post delivery, hemoglobin (Hb), Hematocrit (Ht) and ferritin at the age of 4 months.<br>